{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:01:36Z","timestamp":1792555296295,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970612"],"award-info":[{"award-number":["81970612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300797"],"award-info":[{"award-number":["82300797"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ejim.2024.02.014","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T21:10:44Z","timestamp":1709586644000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Personalized decision support system for tailoring IgA nephropathy treatment strategies"],"prefix":"10.1016","volume":"124","author":[{"given":"Jiaxing","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1834-0520","authenticated-orcid":false,"given":"Rongxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5799-0648","authenticated-orcid":false,"given":"Yuanlin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4246-5431","authenticated-orcid":false,"given":"Wei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2024.02.014_bib0001","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.02.014_bib0002","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1038\/s41598-020-63170-w","article-title":"The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: a network meta-analysis","volume":"10","author":"Tan","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2024.02.014_bib0003","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2024.02.014_bib0004","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2017.9362","article-title":"Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial","volume":"318","author":"Lv","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2024.02.014_bib0005","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","article-title":"Intensive supportive care plus immunosuppression in IgA nephropathy","volume":"373","author":"Rauen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.02.014_bib0006","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1053\/j.ajkd.2019.02.016","article-title":"Prediction and risk stratification of kidney outcomes in IgA nephropathy","volume":"74","author":"Chen","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2024.02.014_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102657","article-title":"Identification and external validation of IgA nephropathy patients benefiting from immunosuppression therapy","volume":"52","author":"Chen","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejim.2024.02.014_bib0008","doi-asserted-by":"crossref","first-page":"234","DOI":"10.21037\/atm.2018.12.11","article-title":"Random forest can accurately predict the development of end-stage renal disease in immunoglobulin a nephropathy patients","volume":"7","author":"Han","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ejim.2024.02.014_bib0009","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.kint.2020.07.046","article-title":"Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy","volume":"99","author":"Schena","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2024.02.014_bib0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/db18-0892","article-title":"A network analysis of biomarkers for type 2 diabetes","volume":"68","author":"Huang","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.ejim.2024.02.014_bib0011","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/med.21293","article-title":"Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers","volume":"34","author":"Liu","year":"2014","journal-title":"Med Res Rev"},{"key":"10.1016\/j.ejim.2024.02.014_bib0012","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2001-1326-3-16","article-title":"Network biomarkers, interaction networks and dynamical network biomarkers in respiratory diseases","volume":"3","author":"Wu","year":"2014","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.ejim.2024.02.014_bib0013","article-title":"Association of obesity with the development of end stage renal disease in IgA nephropathy patients","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ejim.2024.02.014_bib0014","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12882-021-02453-4","article-title":"Cigarette smoking may accelerate the progression of IgA nephropathy","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ejim.2024.02.014_bib0015","article-title":"Arterial-arteriolar sclerosis is independently associated with poor renal outcome in IgA nephropathy patients","volume":"8","author":"Dong","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ejim.2024.02.014_bib0016","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrneph.2017.67","article-title":"Glomerular disease: updated oxford classification of IgA nephropathy: a new MEST-C score","volume":"13","author":"Markowitz","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2024.02.014_bib0017","article-title":"Global glomerulosclerosis and segmental glomerulosclerosis could serve as effective markers for prognosis and treatment of IgA vasculitis with nephritis","volume":"7","author":"Tan","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ejim.2024.02.014_bib0018","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10238-021-00703-1","article-title":"Mesangial IgM deposition predicts renal outcome in patients with IgA nephropathy: a multicenter, observational study","volume":"21","author":"Tan","year":"2021","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.ejim.2024.02.014_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110354","article-title":"Roles of mesangial C3 and C1q deposition in the clinical manifestations and prognosis of IgAN","volume":"120","author":"Wang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ejim.2024.02.014_bib0020","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.7150\/ijms.60111","article-title":"Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients","volume":"18","author":"Jiang","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.ejim.2024.02.014_bib0021","article-title":"Serum bilirubin is correlated with the progression of IgA vasculitis with nephritis","volume":"8","author":"Tan","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ejim.2024.02.014_bib0022","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11255-020-02644-2","article-title":"Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria","volume":"53","author":"Zhong","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ejim.2024.02.014_bib0023","doi-asserted-by":"crossref","first-page":"e20513","DOI":"10.1097\/MD.0000000000020513","article-title":"Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria","volume":"99","author":"Pei","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2024.02.014_bib0024","doi-asserted-by":"crossref","first-page":"8736","DOI":"10.1021\/acs.chemrev.3c00189","article-title":"Machine learning methods for small data challenges in molecular science","volume":"123","author":"Dou","year":"2023","journal-title":"Chem Rev"},{"key":"10.1016\/j.ejim.2024.02.014_bib0025","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41467-022-29968-0","article-title":"A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease","volume":"13","author":"Cheng","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejim.2024.02.014_bib0026","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.2174\/1381612826666200116145057","article-title":"A survey of network representation learning methods for link prediction in biological network","volume":"26","author":"Peng","year":"2020","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ejim.2024.02.014_bib0027","doi-asserted-by":"crossref","first-page":"9725","DOI":"10.1109\/TPAMI.2021.3125687","article-title":"Adaptive graph auto-encoder for general data clustering","volume":"44","author":"Li","year":"2022","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"10.1016\/j.ejim.2024.02.014_bib0028","first-page":"2313","article-title":"Auto-encoding and distilling scene graphs for image captioning","volume":"44","author":"Yang","year":"2022","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"10.1016\/j.ejim.2024.02.014_bib0029","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.semnephrol.2018.05.013","article-title":"Epidemiology of IgA nephropathy: a global perspective","volume":"38","author":"Schena","year":"2018","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ejim.2024.02.014_bib0030","article-title":"Immunosuppressive agents for treating IgA nephropathy","volume":"3","author":"Natale","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2024.02.014_bib0031","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1517\/14656566.2015.1038238","article-title":"The long-term efficacy and safety of immunosuppressive therapy on the progression of IgA nephropathy: a meta-analysis of controlled clinical trials with more than 5-year follow-up","volume":"16","author":"Tian","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ejim.2024.02.014_bib0032","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ekir.2018.03.006","article-title":"Comparative efficacy and safety of therapies in IgA nephropathy: a network meta-analysis of randomized controlled trials","volume":"3","author":"Yang","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ejim.2024.02.014_bib0033","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","article-title":"Machine learning in medicine","volume":"132","author":"Deo","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2024.02.014_bib0034","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","article-title":"A guide to machine learning for biologists","volume":"23","author":"Greener","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ejim.2024.02.014_bib0035","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1038\/s41467-022-31771-w","article-title":"Intratumor graph neural network recovers hidden prognostic value of multi-biomarker spatial heterogeneity","volume":"13","author":"Qiu","year":"2022","journal-title":"Nat Commun"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524000682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524000682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T15:38:28Z","timestamp":1717515508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524000682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":35,"alternative-id":["S0953620524000682"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.02.014","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personalized decision support system for tailoring IgA nephropathy treatment strategies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}